Surgery Partners, Inc.

NASDAQ:SGRY

Medical - Care Facilities

Healthcare
$26.96 +0.39%

+$0.06 today

Market cap
$3.53B
Beta
1.95
P/E (TTM)
-24.1
EPS (TTM)
-$0.59
52W Low $11.41High $24.10

Volume 3.24M

Average 1.36M

SGRY Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Surgery Partners, Inc.NASDAQ: SGRY

Net Income · Q3 FY2026 · quarter ended Sep 2026

Net income dips below year-ago levels

Q3 FY2026 net income of $14.1M fell 44.3% year over year, behind the +230.0% change in trailing-twelve-month net income. Sequentially, it fell 60.7% from the prior quarter. Over 3 fiscal years it compounded at +4.4% a year.

Context

  • Net income amounted to 3.0% of revenue in FY2025, up 2.6 pp from a year earlier.
  • Net income increased in 2 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 5 analysts of $48M (-51.5%) for the fiscal year ending Dec 2026, a slowdown from the +691.2% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
$14.1M-60.7% QoQ
Last fiscal yearDec 2025
$98.9M+691.2% YoY
LTMSep 2026
$76.9M+230.0% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-44.3%+24.6%+68.8 pp
1 year+691.2%-51.5%-742.7 pp
3-year CAGR+4.4%-11.9%-16.3 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
98.9M USD
Year-over-year change
+691.2%
4-year CAGR
+8.8%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How SGRY compares with its peers on the latest reported figures

  • SGRY's LTM Sep 2026 net income of $76.9M is the smallest of the 7 companies compared; the peer median is $1.01B.
  • Its year-over-year change of +230.0% is the highest of 7, against a peer median of +15.7%.
  • Net income amounts to 2.3% of revenue for SGRY, versus a peer median of 8.6%.
SGRY Competitors Peer median
Net Income for SGRY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HCAHCA Healthcare, Inc.LTM Jun 2026$6.84B +3.1%-0.2%8.8%
THCTenet Healthcare CorporationLTM Jun 2026$2.68B +11.9%+12.0%12.3%
UHSUniversal Health Services, Inc.LTM Jun 2026$1.53B +19.5%+32.0%8.4%
CYHCommunity Health Systems, Inc.LTM Mar 2026$497M +202.1%+144.9%2.3%
NUTXNutex Health, Inc.LTM Mar 2026$187.54M +33.9%—21.3%
ARDTArdent Health Partners, LLCLTM Mar 2026$186.34M -23.1%-4.6%2.9%
SGRYSurgery Partners, Inc.LTM Sep 2026$76.9M +230.0%+4.4%2.3%
Peer median (excluding SGRY) $1.01B+15.7%+12.0%8.6%

Competitors are the stored peer set for SGRY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income70.7M87M135.3M12.5M98.9M
Depreciation & Amortization98.8M114.8M118.1M152.6M176M
Deferred Income Tax8.9M21.9M(1.7M)131.5M16.7M
Stock-Based Compensation17.4M18.4M17.7M33.3M14.8M
Change in Working Capital(149.1M)(102.3M)(62.3M)(118.9M)(110.4M)
Accounts Receivables(32.1M)(35.3M)(47.2M)(72.1M)(53.8M)
Inventory00000
Accounts Payables00000
Other Working Capital(117M)(67M)(15.1M)(46.8M)(56.6M)
Other Non-Cash Items40.4M19M86.7M89.1M78.3M
Operating Cash Flow87.1M158.8M293.8M300.1M274.3M
Capital Expenditures(57.6M)(80.6M)(88.8M)(90.4M)(78.7M)
Acquisitions (Net)(280.4M)(228.7M)(128.9M)(378.8M)(162.1M)
Purchases of Investments000(1.7M)(13.3M)
Sales of Investments0004.6M0
Other Investing Activities6.3M1.4M(7.9M)(22.2M)7.5M
Investing Cash Flow(331.7M)(307.9M)(225.6M)(488.5M)(246.6M)
Debt Repayment(43.8M)(644.2M)19.5M450.4M158.7M
Common Stock Issued581.8M882.9M000
Common Stock Repurchased00000
Dividends Paid(5.1M)0000
Other Financing Activities(216.6M)(196.6M)(174.7M)(188.4M)(216M)
Financing Cash Flow316.3M42.1M(155.2M)262M(57.3M)
Effect of Forex Changes00000
Net Change in Cash71.7M(107M)(87M)73.6M(29.6M)
Free Cash Flow29.5M78.2M205M209.7M195.6M

Surgery Partners, Inc.

NASDAQ:SGRY

Intrinsic Alpha fair value

Locked

Current Price

$26.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.